These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 2886644

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.
    Hahn RA, Wardell JR, Sarau HM, Ridley PT.
    J Pharmacol Exp Ther; 1982 Nov; 223(2):305-13. PubMed ID: 6127401
    [Abstract] [Full Text] [Related]

  • 10. Effect of dopamine, ibopamine, and epinine on alpha- and beta-adrenoceptors in canine pulmonary circulation.
    Shebuski RJ, Smith JM, Ruffolo R.
    Fundam Clin Pharmacol; 1989 Nov; 3(3):211-21. PubMed ID: 2548941
    [Abstract] [Full Text] [Related]

  • 11. Analysis of the effects of dopamine-1 and dopamine-2 receptor agonists on coronary flow.
    Zhao RR, Wang PH, Zhang WF, Fennell WH.
    Methods Find Exp Clin Pharmacol; 1992 Nov; 14(1):5-11. PubMed ID: 1352371
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of ibopamine on systemic, pulmonary and regional hemodynamics. Experimental investigations in anesthetized dogs.
    Merlo L, Ghirardi P, Brusoni B, Mussini E, Marchetti G.
    Arzneimittelforschung; 1986 Feb; 36(2A):304-11. PubMed ID: 3707641
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats.
    Chen CJ, Apparsundaram S, Lokhandwala MF.
    J Pharmacol Exp Ther; 1991 Feb; 256(2):486-91. PubMed ID: 1671595
    [Abstract] [Full Text] [Related]

  • 17. Effect of ibopamine on diuresis and arterial blood pressure in anesthetized rats and its interactions with dopaminergic and alpha- and beta-adrenergic antagonists.
    Ferrini R, Miragoli G.
    Arzneimittelforschung; 1986 Feb; 36(2A):323-6. PubMed ID: 2871844
    [Abstract] [Full Text] [Related]

  • 18. Demonstration of specific dopamine-1 receptor-mediated coronary vasodilation in the anesthetized dog.
    Kopia GA, Valocik RE.
    J Pharmacol Exp Ther; 1989 Jan; 248(1):215-21. PubMed ID: 2563287
    [Abstract] [Full Text] [Related]

  • 19. Effect of fenoldopam on the acute and subacute nephrotoxicity produced by amphotericin B in the dog.
    Nichols AJ, Koster PF, Brooks DP, Ruffolo RR.
    J Pharmacol Exp Ther; 1992 Jan; 260(1):269-74. PubMed ID: 1346161
    [Abstract] [Full Text] [Related]

  • 20. Increase in plasma renin activity evoked by fenoldopam in dogs is directly mediated by dopamine1 receptor stimulation.
    Montier F, Katchadourian P, Pratz J, Cavero I.
    J Cardiovasc Pharmacol; 1989 May; 13(5):739-47. PubMed ID: 2472522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.